US-based intelligent workflow management company Forcura and clinical decision support company Medalogix have merged to create a post-acute care technology platform.
The merger will leverage artificial intelligence to optimise patient care delivery, improve outcomes, and drive better business performance for post-acute care providers.
It will enable providers to streamline patient care transitions, simplify collaboration, and enhance end-of-life care management through a single platform.
The combined company aims to advance intelligent patient care for home-based care providers and the broader healthcare continuum.
Berkshire Partners will hold the majority ownership in the new organisation, with The Vistria Group as the largest minority shareholder.
Berkshire Partners managing director Sam Spirn said: “We are thrilled to bring these companies together to help create a leading technology platform that solves real pain points for providers and other stakeholders and ultimately helps to drive better patient care.”
Berkshire Partners managing director Jon Nuger said: “We look forward to building a leading organization focused on growth and innovation that aims to deliver significant value to customers across the healthcare continuum.”
Vistria Group senior partner and healthcare co-head David Schuppan said: “We are thrilled to be a part of the next chapter of Medalogix’s journey with Forcura.
“Their combined capabilities will continue to be transformative for enabling superior in-home care delivery effectiveness and efficiency; ensuring patients receive the right care at the right time in their preferred setting.”
Forcura is a healthcare SaaS technology company, offering intelligent workflow, collaboration, and connectivity solutions that enhance continuity of care.
Established in 2012, Medalogix specialises in data analytics solutions for home health and hospice agencies, using data science and machine learning.
As part of the merger, Forcura founder and CEO Craig Mandeville will be appointed as a member of the Board of Directors of the combined business.
Medalogix CEO Elliott Wood will become CEO of the combined business.
The combined, post-acute care technology platform aims to transform patient experiences, and better connect providers within the healthcare ecosystem.
Also, it will enable equitable reimbursements as the sector shifts towards value-based care.
Kirkland & Ellis and Ropes & Gray served as legal counsel for the transaction, while Houlihan Lokey and William Blair served as exclusive financial advisors for Forcura and Medalogix, respectively.
Mandeville said: “We look forward to our next chapter with Medalogix, where we sustain our commitment to empower better patient care and elevate the role of post-acute providers across the healthcare continuum.
Forcura new president and chief transformation officer Annie Erstling said: “This investment from Berkshire and Vistria will accelerate our joint development, alongside Medalogix, of a groundbreaking post-acute care technology platform that drives significant value for providers, payers, and patients.”
Elliott Wood said: “We’re excited to join forces with Forcura to maximise the reach and impact of our clinical decision support technology and help evolve how providers care for patients and guide them to the best care setting while also achieving operational excellence.”
